FMP

FMP

Enter

ASND - Ascendis Pharma A/S

Discounted Cash Flow Model Levered of Ascendis Pharma A/S(ASND), Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medic

photo-url-https://financialmodelingprep.com/image-stock/ASND.png

Ascendis Pharma A/S

ASND

NASDAQ

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

145.23 USD

-0.81 (-0.558%)

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep